4//SEC Filing
Rizvi Sabina 4
Accession 0001493152-22-020521
CIK 0001415684other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 4:17 PM ET
Size
5.3 KB
Accession
0001493152-22-020521
Insider Transaction Report
Form 4
MusclePharm CorpMSLP
Rizvi Sabina
DirectorPresident & CFO
Transactions
- Award
Options (right to buy)
2021-12-21+1,811,000→ 1,811,000 totalExercise: $0.40From: 2022-04-01Exp: 2031-12-22→ Common stock (1,811,000 underlying)
Footnotes (1)
- [F1]Options were granted pursuant to MusclePharm Corporation's 2021 Omnibus Equity Incentive Plan and vested fully on April 1, 2022.
Documents
Issuer
MusclePharm Corp
CIK 0001415684
Entity typeother
Related Parties
1- filerCIK 0001935157
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 4:17 PM ET
- Size
- 5.3 KB